Home / Publication / Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Publication

Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Author(s): Mitra Abbasi, Ben Small, Nikunjkumar Patel, Masoud Jamei, Sebastian Polak

Year: November 23, 2016

Recommended for you

Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Early Assessment of Proarrhythmic Risk of Drugs Using the In Vitro Data and Single-cell-based In Silico Models: Proof of Concept

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

The Top 10 Things You Need to Know About ADNCA Datasets

Redefining Every Stage of Investment (RESI) Seed to Exit

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

Newsletter sign up

Quick links

Solutions

Contact